Andrew Lees (vaccinologist)
Andrew Lees | |
|---|---|
| Born | February 1953 (age 73) Massachusetts, United States |
| Education | Harvey Mudd College, Johns Hopkins University |
| Occupation | Vaccine chemist |
| Known for | Developing the CDAP conjugation method |
| Medical career | |
| Profession | Vaccinologist |
| Field | Biochemistry |
| Institutions | Fina Biosolutions |
Andrew Lees (born February 1953 in Massachusetts, United States) is an American vaccine chemist known for developing the CDAP conjugation method], used in vaccines manufactured by GlaxoSmithKline (Streptococcus pneumoniae, Neisseria meningitidis ) and conjugate vaccines currently in clinical development by the Serum Institute of India and Chengdu Institute of Biological Products. Lees holds 25 patents in the area of conjugate vaccines.